why choose us

Clinical Trials Search

Showing 14,630 of 132,963 result(s)
Familial Hyperlipidemia Family Registry

Status: ACTIVE_NOT_RECRUITING

Condition: Familial Hyperlipidemia

Interventions:

Date: 2023-03-02

Absorption, Metabolism, and Excretion of CYC065 in Healthy Male Subjects

Status: ACTIVE_NOT_RECRUITING

Condition: Healthy

Interventions: Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-CYC065 Following a Single Oral Dose in Healthy Male Subjects

Date: 2023-03-02

Porcine Membrane vs Bovine Wound Dressing in Human Tooth Extraction Sites

Status: Completed

Condition: Wound Heal

Interventions: Atraumatic tooth extraction with porcine collagen membrane placement

Date: 2023-03-02

GetUp&Go: A Randomized Controlled Trial of an Intervention to Enhance Physical Activity After TBI

Status: Completed

Condition: Traumatic Brain Injury

Interventions: A behavioral treatment combining personalized activity planning and a mobile health application for supporting adherence to activity plans.

Date: 2023-03-02

Uncertainty and Firearms: Obtaining Secure Storage

Status: Completed

Condition: Anxiety

Interventions: The research interventionist uses a guiding approach to identify methods for secure firearm storage and reflects the participant's reasons for an

Date: 2023-03-02

Antimicrobial Revision in Persistent Febrile Neutropenia

Status: NOT_YET_RECRUITING

Condition: Febrile Neutropenia

Interventions: Carbapenem antibiotic

Date: 2023-03-02

Rapid Adaptation to Prevent Drug Use

Status: NOT_YET_RECRUITING

Condition: Substance Use

Interventions: RAPD will include a novel bundle of implementation strategies to support rapid responses to urgent drug use events.
The strategies deployed will

Date: 2023-03-02

Bioequivalence of a Zanubrutinib Tablet Compared to Capsules in Healthy Adult Participants

Status: COMPLETED

Condition: Healthy Volunteers

Interventions: Administered as a tablet or capsule

Date: 2023-03-02

Telemedicine for Home-based Management of Patients With Chronic Kidney Diseases and Comorbidities (NET-2018-12367206)

Status: Completed

Condition: Chronic Kidney Diseases

Interventions:

Date: 2023-03-02

P3 Study to Assess Efficacy and Safety of Cefepime;Nacubactam and Aztreonam;Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales

Status: Completed

Condition: Complicated Urinary Tract Infection

Interventions: 2 g cefepime and 1 g nacubactam every 8 hours for at least 5 days and up to 14 days via IV infusion over a period of 60 minutes

Date: 2023-03-02